Clinical Trial Update: Use of IL-15 After Chemotherapy and Lymphocyte Transfer in Metastatic Melanoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating interleukin-15 after chemotherapy and lymphocyte transfer in metastatic melanoma; the study was terminated and results were posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Skin Cancer

Drugs mentioned

• Interleukin-15 (interleukin-15)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Metastatic Melanoma, Skin Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2015-01-27